The deubiquitinating enzyme Otu1 releases substrates from the conserved initiation complex of the Cdc48/p97 ATPase for proteasomal degradation

This study reveals that the deubiquitinating enzyme Otu1 (Yod1) prevents substrates from being trapped in futile cycles on the Cdc48/p97 ATPase by trimming their ubiquitin chains prior to translocation, thereby facilitating their efficient transfer to the proteasome for degradation through a conserved mechanism involving simultaneous cofactor binding and ubiquitin unfolding.

The Gist

The Big Picture: The Cell's Recycling Plant

Imagine your cell is a bustling city. Every day, it produces proteins (the workers and machines) that eventually get old, broken, or damaged. To keep the city clean, the cell has a recycling plant called the 26S proteasome. Its job is to chop up these broken proteins into tiny pieces so they can be reused.

But there's a problem: Some broken proteins are folded up so tightly (like a knotted ball of yarn) that the recycling plant can't grab them. They need to be pulled apart first.

The Problem: The "Tug-of-War" Machine

Enter the Cdc48/p97 machine. Think of this as a powerful industrial winch or a conveyor belt.

1. The Tag: Broken proteins are marked with a "do not recycle yet" tag made of a chain of small beads called ubiquitin.
2. The Winch: The Cdc48 machine grabs these tagged proteins. It uses energy (ATP) to pull the protein through its tiny central hole, unraveling the tight knots so the recycling plant can eat them.
3. The Glitch: Sometimes, this winch gets stuck in a loop. It pulls the protein through, the protein gets released, but because the "ubiquitin tag" is still long and sticky, the winch grabs it again. It pulls it through, releases it, and grabs it again. This is a futile cycle—the machine is working hard but not actually getting the job done. The protein is trapped in a loop of being pulled and released, never reaching the recycling plant.

The Hero: The "Chain-Cutter" (Otu1/Yod1)

The scientists in this paper discovered a specific tool that fixes this loop: an enzyme called Otu1 (known as Yod1 in humans).

Think of Otu1 as a smart pair of scissors or a trimmer.

• When the protein is stuck on the winch, Otu1 comes along and snips off the extra length of the ubiquitin chain.
• It doesn't remove the whole chain (the recycling plant still needs a little bit of the tag to recognize the protein), but it trims it down just enough.
• The Result: Once the chain is trimmed, the protein is no longer "sticky" enough for the winch to grab it again. The winch lets go, and the protein is free to be picked up by the recycling plant (proteasome) and finally destroyed.

The Discovery: How It All Fits Together

The researchers didn't just guess this; they built a 3D model of the machine using a super-powerful microscope (Cryo-EM) to see exactly how it works.

1. The Team-Up: They found that the winch (p97), the helper proteins (Ufd1-Npl4), the "chain-cutter" (Yod1), and the protein itself can all sit on the machine at the same time. It's like a pit crew working on a race car simultaneously.
2. The Unfolding: They saw that the machine starts by grabbing one specific bead (the "initiator ubiquitin") from the chain and pulling it through the hole. This is the key that unlocks the whole process.
3. The Conservation: They found that this mechanism is almost identical in yeast (simple cells) and humans. This means nature has used this same "winch and trimmer" design for billions of years.

Why Does This Matter?

This discovery is a big deal for two reasons:

1. Understanding Disease: If this "trimming" process fails, broken proteins can pile up in the cell. This is linked to diseases like cancer and neurodegenerative disorders (like Alzheimer's).
2. New Medicine: Since the p97 winch is often overactive in cancer cells, scientists are trying to design drugs to stop it. This paper gives them a new blueprint. Instead of just trying to stop the winch from spinning, they could design drugs that jam the "initiator bead" into the machine or block the "chain-cutter" from working, effectively freezing the cancer cell's recycling system.

Summary Analogy

• The Broken Protein: A tangled ball of yarn.
• The Ubiquitin Chain: A long, sticky rope tied to the yarn.
• The Cdc48/p97 Machine: A winch that tries to pull the yarn through a small hole.
• The Problem: The rope is too long, so the winch keeps grabbing the yarn, pulling it, letting go, and grabbing it again in a useless loop.
• The Solution (Otu1/Yod1): A pair of scissors that cuts the rope shorter.
• The Outcome: The rope is now short enough that the winch lets go, and the Recycling Plant can finally take the yarn and shred it.

Technical Summary

1. Problem Statement

In eukaryotic cells, regulated protein degradation often involves the attachment of polyubiquitin chains to target proteins. While flexible substrates can be directly degraded by the 26S proteasome, well-folded proteins require the AAA+ ATPase Cdc48 (in yeast) or its mammalian homolog p97/VCP to unfold them before translocation into the proteasome.

• The Mechanism Gap: The current model suggests that Cdc48/p97, in complex with cofactors Ufd1-Npl4 (UN), binds polyubiquitinated substrates. An "initiator" ubiquitin molecule is unfolded and inserted into the ATPase pore to begin translocation. However, this process can lead to a "futile cycle" where substrates are repeatedly translocated and re-bound without being degraded.
• The Unknown: It is unclear how substrates escape this cycle to be transferred to the proteasome. Previous hypotheses suggested the deubiquitinating enzyme (DUB) Otu1 (Yod1 in mammals) might be required for translocation, but later data suggested it might instead release substrates. The structural basis for how Otu1 interacts with the Cdc48/p97 complex and how it facilitates substrate release remained unresolved.

2. Methodology

The authors employed a combination of in vitro biochemical assays and high-resolution structural biology:

• Reconstituted Degradation Assays: Using purified components (Cdc48/p97, UN complex, Otu1/Yod1, Ubx5, Rad23, 26S proteasomes, and fluorescently labeled substrates like Ub(n)-TAIL and Ub(n)-FOLD), the authors monitored substrate degradation and deubiquitination via SDS-PAGE and fluorescence scanning.
• Pull-down Experiments: To test simultaneous binding, the authors used FLAG-tagged or SBP-tagged proteins (including catalytically inactive mutants like Otu1-C120S and Yod1-C160S) to assemble supercomplexes on beads. They utilized ATP$\gamma$S to lock the ATPase in a specific state and analyzed co-purification of cofactors (Npl4, Ufd1, Ubx5, Otu1/Yod1) and substrates.
• Cryo-Electron Microscopy (cryo-EM):
  • Sample: A human p97 complex containing p97-E578Q (Walker B mutant to slow translocation), human UN, Yod1-C160S (catalytically inactive), UBXN7 (human Ubx5 homolog), and polyubiquitinated substrate.
  • Processing: Approximately 800,000 particles were processed using CryoSPARC, resulting in a global resolution of 2.97 Å and a locally refined resolution of 3.05 Å for the D1 ring and Npl4 tower.
  • Modeling: Rigid body fitting and de novo model building were performed using existing structures (PDB: 7LMZ, 7WWQ) and AlphaFold predictions.

3. Key Results

A. Biochemical Function of Otu1/Yod1

• Release from Cdc48: In the presence of Cdc48-UN, substrate degradation is inhibited because the ATPase competes with the proteasome. The addition of Otu1 relieves this inhibition, allowing the substrate to be degraded by the proteasome.
• Mechanism of Release: Otu1 does not remove the entire ubiquitin chain. Instead, it trims the chain. The remaining chain (containing ~3-4 ubiquitins) is sufficient for proteasome recognition but too short for efficient rebinding to the Cdc48-UN-Ubx5 complex.
• Timing: Using ATPase mutants defective in translocation (K261A in D1, E588Q in D2), the authors demonstrated that Otu1-mediated trimming and substrate release occur before the initiation of polypeptide translocation through the ATPase pore.
• Domain Requirement: The UBXL domain of Otu1, which binds to the N-domain of Cdc48, is essential for stimulating degradation, indicating that physical tethering to the ATPase enhances Otu1's activity.

B. Structural Insights (Human p97 Complex)

• Supercomplex Assembly: The cryo-EM structure confirms that p97, UN, Yod1, UBXN7, and the polyubiquitinated substrate can form a stable supercomplex simultaneously. This validates the pull-down data showing that multiple cofactors bind the hexameric ring concurrently.
• Conserved Initiation Mechanism: The structure reveals an unfolded initiator ubiquitin (unUb) extending from the Npl4 groove, through the central pore of the D1 ring, and engaging the pore loops of the D2 ring.
  • The Npl4 groove has a kink that accommodates the unfolded ubiquitin.
  • The N-terminus of the unfolded ubiquitin projects across both ATPase rings, engaging the D2 ring in a "staircase" conformation, supporting a conveyor belt mechanism for pulling the substrate.
• Ubiquitin Chain Architecture:
  • Two folded ubiquitin molecules (distal to the initiator) are visible on top of the Npl4 tower.
  • Unlike previous yeast structures where distal ubiquitins appeared too far apart to be linked, the human structure shows a continuous chain where Ub1 and Ub2 are linked, confirming the presence of a polyubiquitin chain on the complex.
• Conformational Changes: Binding of the unfolded ubiquitin induces a conformational change in the Npl4 groove, widening it to accommodate the substrate.

4. Key Contributions

1. Resolution of the "Futile Cycle": The study definitively shows that Otu1/Yod1 breaks the futile cycle of repeated substrate unfolding by trimming the ubiquitin chain prior to translocation. This reduces the affinity of the substrate for the Cdc48 complex, favoring transfer to the proteasome.
2. Structural Conservation: The cryo-EM structure of the human p97 complex confirms that the mechanism of substrate initiation (unfolding of an initiator ubiquitin by Npl4 and insertion into the pore) is evolutionarily conserved between yeast and mammals, despite previous conflicting structural data.
3. Supercomplex Visualization: The paper provides the first high-resolution view of the p97 complex simultaneously bound to its substrate, the UN complex, the DUB (Yod1), and the recruitment factor (UBXN7).
4. Drug Target Implications: By revealing the specific interface where the unfolded ubiquitin binds to the Npl4 groove, the study identifies a new potential target for cancer therapeutics. Inhibitors could be designed to block this specific interaction, disrupting the p97-UN complex formation.

5. Significance

This work fundamentally advances the understanding of the ubiquitin-proteasome system (UPS). It clarifies the regulatory role of DUBs not just as "erasers" of ubiquitin signals, but as gatekeepers that determine the fate of a substrate (degradation vs. recycling). By demonstrating that Otu1 trims the chain to facilitate transfer to the proteasome, the authors resolve a long-standing paradox in the field. Furthermore, the high-resolution human structure provides a critical template for developing specific inhibitors against p97, a major target in oncology, potentially leading to drugs that disrupt the initiation of substrate processing rather than the ATPase activity itself.